Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis von Wada, Yumiko, Cardinale, Irma, Khatcherian, Artemis, Chu, John, Kantor, Aaron B, Gottlieb, Alice B, Tatsuta, Noriaki, Jacobson, Eric, Barsoum, James, Krueger, James G

Volltext

Axial psoriatic arthritis: An update for dermatologists von Gottlieb, Alice B., Merola, Joseph F.

Volltext

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa von Kimball, Alexa B, Okun, Martin M, Williams, David A, Gottlieb, Alice B, Papp, Kim A, Zouboulis, Christos C, Armstrong, April W, Kerdel, Francisco, Gold, Michael H, Forman, Seth B, Korman, Neil J, Giamarellos-Bourboulis, Evangelos J, Crowley, Jeffrey J, Lynde, Charles, Reguiai, Ziad, Prens, Errol-Prospero, Alwawi, Eihab, Mostafa, Nael M, Pinsky, Brett, Sundaram, Murali, Gu, Yihua, Carlson, Dawn M, Jemec, Gregor B.E

Volltext

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial von McInnes, Iain B, Prof, Mease, Philip J, Prof, Kirkham, Bruce, MD, Kavanaugh, Arthur, Prof, Ritchlin, Christopher T, Prof, Rahman, Proton, Prof, van der Heijde, Désirée, Prof, Landewé, Robert, Prof, Conaghan, Philip G, Prof, Gottlieb, Alice B, Prof, Richards, Hanno, MD, Pricop, Luminita, MD, Ligozio, Gregory, MSc, Patekar, Manmath, MD, Mpofu, Shephard, MD

Volltext

Treatment recommendations for psoriatic arthritis von Ritchlin, C T, Kavanaugh, A, Gladman, D D, Mease, P J, Helliwell, P, Boehncke, W-H, de Vlam, K, Fiorentino, D, FitzGerald, O, Gottlieb, A B, McHugh, N J, Nash, P, Qureshi, A A, Soriano, E R, Taylor, W J

Volltext

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis von Papp, K.A., Reich, K., Paul, C., Blauvelt, A., Baran, W., Bolduc, C., Toth, D., Langley, R.G., Cather, J., Gottlieb, A.B., Thaçi, D., Krueger, J.G., Russell, C.B., Milmont, C.E., Li, J., Klekotka, P.A., Kricorian, G., Nirula, A.

Volltext

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials von Papp, K.A., Menter, M.A., Abe, M., Elewski, B., Feldman, S.R., Gottlieb, A.B., Langley, R., Luger, T., Thaci, D., Buonanno, M., Gupta, P., Proulx, J., Lan, S., Wolk, R.

Volltext

Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients von Menter, Alan, Cordoro, Kelly M., Davis, Dawn M.R., Kroshinsky, Daniela, Paller, Amy S., Armstrong, April W., Connor, Cody, Elewski, Boni E., Gelfand, Joel M., Gordon, Kenneth B., Gottlieb, Alice B., Kaplan, Daniel H., Kavanaugh, Arthur, Kiselica, Matthew, Kivelevitch, Dario, Korman, Neil J., Lebwohl, Mark, Leonardi, Craig L., Lichten, Jason, Lim, Henry W., Mehta, Nehal N., Parra, Sylvia L., Pathy, Arun L., Farley Prater, Elizabeth A., Rupani, Reena N., Siegel, Michael, Stoff, Benjamin, Strober, Bruce E., Wong, Emily B., Wu, Jashin J., Hariharan, Vidhya, Elmets, Craig A.

Volltext

Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial von Casseres, Rachel G., Prussick, Lisa, Zancanaro, Pedro, Rothstein, Brooke, Joshipura, Deep, Saraiya, Ami, Turkowski, Yana, Au, Shiu Chung, Alomran, Abdulaziz, Abdat, Rana, Abudu, Minawaer, Kachuk, Courtney, Dumont, Nicole, Gottlieb, Alice B., Rosmarin, David

Volltext

Open‐label, investigator‐initiated, single‐site exploratory trial evaluating secukinumab, an anti‐interleukin‐17A monoclonal antibody, for patients with moderate‐to‐severe hidraden... von Prussick, L., Rothstein, B., Joshipura, D., Saraiya, A., Turkowski, Y., Abdat, R., Alomran, A., Zancanaro, P., Kachuk, C., Dumont, N., Gottlieb, A.B., Rosmarin, D.

Volltext

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial von Papp, K., Thaçi, D., Reich, K., Riedl, E., Langley, R.G., Krueger, J.G., Gottlieb, A.B., Nakagawa, H., Bowman, E.P., Mehta, A., Li, Q., Zhou, Y., Shames, R.

Volltext

Comorbidities in Patients with Psoriasis von Gottlieb, Alice B., MD, PhD, Dann, Frank, MD

Volltext

A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process von Thorlacius, L., Ingram, J.R., Villumsen, B., Esmann, S., Kirby, J.S., Gottlieb, A.B., Merola, J.F., Dellavalle, R., Nielsen, S.M., Christensen, R., Garg, A., Jemec, G.B.E.

Volltext

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib von Rothstein, Brooke, BA, Joshipura, Deep, MBBS, MD, Saraiya, Ami, MD, Abdat, Rana, MD, Ashkar, Huda, MD, Turkowski, Yana, MD, Sheth, Vaneeta, MD, Huang, Victor, MD, Au, Shiu Chung, MD, Kachuk, Courtney, RN, Dumont, Nicole, Gottlieb, Alice B., MD, PhD, Rosmarin, David, MD

Volltext

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Cl... von Gottlieb, Alice B, Deodhar, Atul, Mcinnes, Iain B, Baraliakos, Xenofon, Reich, Kristian, Schreiber, Stefan, Bao, Weibin, Marfo, Kwaku, Richards, Hanno B, Pricop, Luminita, Shete, Abhijit, Trivedi, Vivek, Keefe, Deborah, Papavassilis, Charis C, Jagiello, Piotr, Papanastasiou, Philemon, Mease, Philip J, Lebwohl, Mark

Volltext

Specific targeting of interleukin-23p19 as effective treatment for psoriasis von Levin, Adriane A., BA, Gottlieb, Alice B., MD, PhD

Volltext

A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis von Gottlieb, A.B., Langley, R.G., Strober, B.E., Papp, K.A., Klekotka, P., Creamer, K., Thompson, E.H.Z., Hooper, M., Kricorian, G.

Volltext

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis von Armstrong, April W., MD, MPH, Siegel, Michael P., PhD, Bagel, Jerry, MD, Boh, Erin E., MD, PhD, Buell, Megan, Cooper, Kevin D., MD, Callis Duffin, Kristina, MD, MS, Eichenfield, Lawrence F., MD, Garg, Amit, MD, Gelfand, Joel M., MD, MSCE, Gottlieb, Alice B., MD, PhD, Koo, John Y.M., MD, Korman, Neil J., MD, PhD, Krueger, Gerald G., MD, Lebwohl, Mark G., MD, Leonardi, Craig L., MD, Mandelin, Arthur M., MD, PhD, Menter, M. Alan, MD, Merola, Joseph F., MD, MMSC, Pariser, David M., MD, Prussick, Ronald B., MD, FRCP, Ryan, Caitriona, MD, Shah, Kara N., MD, Weinberg, Jeffrey M., MD, Williams, MaryJane O.U., MD, Wu, Jashin J., MD, Yamauchi, Paul S., MD, PhD, Van Voorhees, Abby S., MD

Volltext

Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate‐to‐severe plaque psoriasis: integrated analysis of the randomized... von Papp, K.A., Gordon, K.B., Langley, R.G., Lebwohl, M.G., Gottlieb, A.B., Rastogi, S., Pillai, R., Israel, R.J.

Volltext

Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab′ certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatme... von Reich, K., Ortonne, J.-P., Gottlieb, A.B., Terpstra, I.J., Coteur, G., Tasset, C., Mease, P.

Volltext